Search Results - "MATTSSON, Jonas"

Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients by Kimura, Muneyoshi, Ferreira, Victor H., Kothari, Sagar, Pasic, Ivan, Mattsson, Jonas I., Kulasingam, Vathany, Humar, Atul, Mah, Allison, Delisle, Jean-Sébastien, Ierullo, Matthew, Majchrzak-Kita, Beata, Kumar, Deepali, Hosseini-Moghaddam, Seyed M.

“…In allogeneic stem cell transplant (Allo-SCT) recipients, the cell-mediated and humoral immunogenicity of the 3-dose SARS-CoV-2 vaccination schedule has not…”
Get full text

CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude by Poiret, Thomas, Vikberg, Sara, Schoutrop, Esther, Mattsson, Jonas, Magalhaes, Isabelle

“…Chimeric antigen receptor (CAR) T cell therapy is associated with high risk of adverse events. Glucocorticoids (GCs) are cornerstone in the management of…”
Get full text

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation by Uhlin, Michael, Wikell, Helena, Sundin, Mikael, Blennow, Ola, Maeurer, Markus, Ringden, Olle, Winiarski, Jacek, Ljungman, Per, Remberger, Mats, Mattsson, Jonas

“…Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic malignancies and a variety of genetic and metabolic disorders. In…”
Get full text

Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease by Novitzky-Basso, Igor, Schain, Frida, Batyrbekova, Nurgul, Webb, Thomas, Remberger, Mats, Keating, Armand, Mattsson, Jonas

“…Chronic graft-versus-host disease (cGVHD) is a serious immune-mediated complication after allogeneic haematopoietic stem cell transplantation (HSCT), but in…”
Get full text

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation by Törlén, Johan, Ringdén, Olle, Garming-Legert, Karin, Ljungman, Per, Winiarski, Jacek, Remes, Kari, Itälä-Remes, Maija, Remberger, Mats, Mattsson, Jonas

“…Improvement of graft-versus-host disease prophylaxis remains an important goal in allogeneic hematopoietic stem cell transplantation. Based on reports of…”
Get full text

The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity by Magalhaes, Isabelle, Yogev, Ohad, Mattsson, Jonas, Schurich, Anna

“…Upon activation naïve T cells undergo metabolic changes to support the differentiation into subsets of effector or regulatory cells, and enable subsequent…”
Get full text

Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation by Salas, Maria Queralt, Atenafu, Eshetu G., Bascom, Ora, Wilson, Leeann, Lam, Wilson, Law, Arjun Datt, Pasic, Ivan, Kim, Dennis (Dong Hwan), Michelis, Fotios V., Al-Shaibani, Zeyad, Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey Howard, Mattsson, Jonas, Alibhai, Shabbir M. H., Kumar, Rajat

“…A Frailty and Functionality evaluation for alloHCT was implemented using existing resources. We describe the implementation of this evaluation across all ages…”
Get full text

Fetal Membrane Cells for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease by Ringdén, Olle, Erkers, Tom, Nava, Silvia, Uzunel, Mehmet, Iwarsson, Erik, Conrad, Réka, Westgren, Magnus, Mattsson, Jonas, Kaipe, Helen

“…The placenta protects the fetus from the mother's immune system. We have previously found that fetal membrane cells (FMCs) isolated from term placenta prevent…”
Get full text

A longitudinal multidimensional rehabilitation program for patients undergoing allogeneic blood and marrow transplantation (CaRE-4-alloBMT): Protocol for a phase II feasibility pilot randomized controlled trial by Tam, Samantha, Kumar, Rajat, Lopez, Paty, Mattsson, Jonas, Alibhai, Shabbir, Atenafu, Eshetu G, Bernstein, Lori J, Chang, Eugene, Clarke, Susan, Langelier, David, Lipton, Jeffrey, Mayo, Samantha, Papadakos, Tina, Jones, Jennifer Michelle

“…Allogeneic blood and marrow transplantation (alloBMT) is a curative treatment for blood cancers associated with various treatment-related adverse events and…”
Get full text

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway by El-Serafi, Ibrahim, Terelius, Ylva, Abedi-Valugerdi, Manuchehr, Naughton, Seán, Saghafian, Maryam, Moshfegh, Ali, Mattsson, Jonas, Potácová, Zuzana, Hassan, Moustapha

“…Busulphan (Bu) is an alkylating agent used in the conditioning regimen prior to hematopoietic stem cell transplantation (HSCT). Bu is extensively metabolized…”
Get full text

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models by Schoutrop, Esther, Poiret, Thomas, El-Serafi, Ibrahim, Zhao, Ying, He, Rui, Moter, Alina, Henriksson, Johan, Hassan, Moustapha, Magalhaes, Isabelle, Mattsson, Jonas

“…BackgroundLimited persistence of functional CAR T cells in the immunosuppressive solid tumor microenvironment remains a major hurdle in the successful…”
Get full text

A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo by Arruda, Lucas C M, Stikvoort, Arwen, Lambert, Melanie, Jin, Liqing, Rivera, Laura Sanchez, Alves, Renato M P, De Moura, Tales Rocha, Mim, Carsten, Lehmann, Sören, Axelsson-Robertson, Rebecca, Dick, John E, Mattsson, Jonas, Önfelt, Björn, Carlsten, Mattias, Uhlin, Michael

“…Less than a third of acute myeloid leukemia (AML) patients are cured by chemotherapy and/or hematopoietic stem cell transplantation (HSCT), highlighting the…”
Get full text

Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress by Renken, Stefanie, Nakajima, Takahiro, Magalhaes, Isabelle, Mattsson, Jonas, Lundqvist, Andreas, Arnér, Elias S J, Kiessling, Rolf, Wickström, Stina Linnea

“…BackgroundAdoptive cell therapy using cytotoxic lymphocytes is an efficient immunotherapy against solid and hematological cancers. However, elevated levels of…”
Get full text

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up by Kim, Kyoung Ha, Kim, TaeHyung, Novitzky-Basso, Igor, Lee, Hyewon, Yoo, Youngseok, Ahn, Jae-Sook, Pasic, Ivan, Law, Arjun, Lam, Wilson, Michelis, Fotios V, Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey, Kumar, Rajat, Mattsson, Jonas, Zhang, Zhaolei, Kaushansky, Nathali, Brilon, Yardena, Chapal-Ilani, Noa, Biezuner, Tamir, Shlush, Liran I, Kim, Dennis Dong Hwan

“…Donor clonal hematopoiesis may be transferred to the recipient through allogeneic hematopoietic stem cell transplantation (HSCT), but the potential for adverse…”
Get full text

Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality by Schoutrop, Esther, Renken, Stefanie, Micallef Nilsson, Isabella, Hahn, Paula, Poiret, Thomas, Kiessling, Rolf, Wickström, Stina L, Mattsson, Jonas, Magalhaes, Isabelle

“…Successful translation of chimeric antigen receptor (CAR) T cell therapy for the treatment of solid tumors has proved to be troublesome, mainly due to the…”
Get full text

Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome by AVETISYAN, Gayane, MATTSSON, Jonas, SPARRELID, Elda, LJUNGMAN, Per

“…Respiratory syncytial virus (RSV) is a common cause of serious respiratory infections in hematopoietic stem-cell transplant (HSCT) recipients. We aimed to…”
Get full text

Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis by Rydén, Mikael, Uzunel, Mehmet, Hård, Joanna L., Borgström, Erik, Mold, Jeff E., Arner, Erik, Mejhert, Niklas, Andersson, Daniel P., Widlund, Yvonne, Hassan, Moustapha, Jones, Christina V., Spalding, Kirsty L., Svahn, Britt-Marie, Ahmadian, Afshin, Frisén, Jonas, Bernard, Samuel, Mattsson, Jonas, Arner, Peter

“…Because human white adipocytes display a high turnover throughout adulthood, a continuous supply of precursor cells is required to maintain adipogenesis. Bone…”
Get full text

Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation by Ringdén, Olle, Sadeghi, Behnam, Moretti, Gianluca, Finnbogadottir, Sigrun, Eriksson, Brita, Mattsson, Jonas, Svahn, Britt-Marie, Remberger, Mats

“…Patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) were given the option to be treated at home during the pancytopenic phase. Daily…”
Get full text

Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation by Cheng, Guang‐Shing, Selwa, Katherine E., Hatt, Charles, Ram, Sundaresh, Fortuna, Aleksa B., Guerriero, Margaret, Himelhoch, Ben, McAree, Daniel, Hoffman, Timothy C., Brisson, Joseph, Nazareno, Ryan, Bloye, Kiernan, Johnson, Timothy D., Remberger, Mats, Mattsson, Jonas, Vummidi, Dharshan, Kazerooni, Ella E., Lama, Vibha N., Galban, Stefanie, Boeckh, Michael, Yanik, Gregory A., Galban, Craig J.

“…Parametric response mapping (PRM) is a novel computed tomography (CT) technology that has shown potential for assessment of bronchiolitis obliterans syndrome…”
Get full text

Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells by Sadeghi, Behnam, Ersmark, Bo, Moretti, Gianluca, Mattsson, Jonas, Ringdén, Olle

“…Mesenchymal stromal cells may reverse acute inflammatory disorders. The placenta is important in feto-maternal tolerance. We have used placenta-derived decidua…”
Get full text